Universe Pharmaceuticals (UPC) Notes Payables: 2020-2024
Historic Notes Payables for Universe Pharmaceuticals (UPC) over the last 5 years, with Sep 2024 value amounting to $5.9 million.
- Universe Pharmaceuticals' Notes Payables rose 6.83% to $5.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.9 million, marking a year-over-year increase of 6.83%. This contributed to the annual value of $5.9 million for FY2024, which is 6.83% up from last year.
- Latest data reveals that Universe Pharmaceuticals reported Notes Payables of $5.9 million as of FY2024, which was up 6.83% from $5.5 million recorded in FY2023.
- Over the past 5 years, Universe Pharmaceuticals' Notes Payables peaked at $2,646.0 billion during FY2020, and registered a low of $3.9 million during FY2022.
- Over the past 3 years, Universe Pharmaceuticals' median Notes Payables value was $5.5 million (recorded in 2023), while the average stood at $5.1 million.
- Its Notes Payables has fluctuated over the past 5 years, first plummeted by 100.00% in 2021, then skyrocketed by 39.28% in 2023.
- Over the past 5 years, Universe Pharmaceuticals' Notes Payables (Yearly) stood at $2,646.0 billion in 2020, then plummeted by 100.00% to $4.3 million in 2021, then decreased by 9.19% to $3.9 million in 2022, then spiked by 39.28% to $5.5 million in 2023, then rose by 6.83% to $5.9 million in 2024.